Publication year: 2011 Source: Journal of Cardiac Failure, Volume 17, Issue 9, September 2011, Pages 703-709 Giuseppe Marazzi, Maurizio Volterrani, Giuseppe Caminiti, Luigi Iaia, Rosalba Massaro, … BackgroundBeta-blockers improve left ventricular (LV) systolic function and prognosis in patients with chronic heart failure (CHF), but their different pleiotropic properties may influence their cardiovascular effects. This open-label study compared the effects of long-term treatment with nebivolol versus carvedilol on LV ejection fraction (LVEF), in hypertensive CHF patients
Original post:
Comparative Long Term Effects of Nebivolol and Carvedilol in Hypertensive Heart Failure Patients